The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH AL 2020 | Germline predisposition to AML
Lucy Godley, MD, PhD, University of Chicago, Chicago, IL, highlights the importance of identifying germline predisposition to hematopoietic malignancies and outlines how to recognize and manage these cases. Additionally, Dr Godley discusses how to differentiate between germline and somatic mutations. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
